| 000 | 01720 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517022228.0 | ||
| 264 | 0 | _c20160322 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1559-131X | ||
| 024 | 7 |
_a10.1007/s12032-015-0550-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDrooger, Jan C | |
| 245 | 0 | 0 |
_aNeutrophil-guided dosing of anthracycline-cyclophosphamide-containing chemotherapy in patients with breast cancer: a feasibility study. _h[electronic resource] |
| 260 |
_bMedical oncology (Northwood, London, England) _cApr 2015 |
||
| 300 |
_a113 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnthracyclines _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEpirubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeutrophils _xpathology |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _avan Pelt-Sprangers, Johanna M | |
| 700 | 1 | _aLeunis, Corry | |
| 700 | 1 | _aJager, Agnes | |
| 700 | 1 | _ade Jongh, Felix E | |
| 773 | 0 |
_tMedical oncology (Northwood, London, England) _gvol. 32 _gno. 4 _gp. 113 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12032-015-0550-x _zAvailable from publisher's website |
| 999 |
_c24709291 _d24709291 |
||